About – Invictus Nutraceuticals

About
Invictus Nutraceuticals

Invictus Nutraceuticals develops and commercializes evidence-based nutraceuticals based on two proprietary and patented delivery platforms for improving the bioavailability and efficacy of tocotrienols (a natural product which is one part of vitamin E).

The Board, Scientific Advisory Board and Management of Invictus Nutraceuticals have a proven track record in using science to create new products and to bring these products to market.

The raison d’être of the Company is using the scientific rigour usually reserved for prescription drug discovery and development in the pharmaceuticals industries to develop nutraceuticals based on a natural product, tocotrienol.

Evidence-based nutraceuticals

Invictus Nutraceuticals has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program that will shortly enter the clinical phase.

nE1-Heart®

nE1-Heart® targeting maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia.

nE1-Elite®

nE1-Elite® reduces Delayed Onset Muscle Soreness (DOMS), improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

CONTACT US

Would you like to know more about Invictus Nutraceuticals and its products?
Contact us today.

NATURALLY DERIVED.
NOVEL SCIENCE.